CAM Capital
North America, New York, United States, New York
Description
CAM Capital engages in both trading activities and fundamentally driven investments.
Investor Profile
CAM Capital has backed more than 27 startups, with 1 new investments in the last 12 months alone. The firm has led 8 rounds, about 30% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Post Ipo Equity, Series C rounds (top funding stages).
- Majority of deals are located in United States, Canada, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series B (37%)
- Post Ipo Equity (30%)
- Series C (15%)
- Series A (11%)
- Seed (4%)
- Series Unknown (4%)
Country Focus
- United States (93%)
- Canada (4%)
- United Kingdom (4%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Life Science
- Biopharma
- Medical
- Pharmaceutical
- Oncology
- Women's
- Diabetes
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
